{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ABC transporters", "Cancer stem cells", "Hedgehog", "NF-\u03baB", "Natural compounds", "Notch", "Wnt"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28367074", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1389202917666160803162309"], "Journal": {"ISSN": "1389-2029", "JournalIssue": {"Volume": "18", "Issue": "2", "PubDate": {"Year": "2017", "Month": "Apr"}}, "Title": "Current genomics", "ISOAbbreviation": "Curr Genomics"}, "ArticleTitle": "Anti-Cancer Phytometabolites Targeting Cancer Stem Cells.", "Pagination": {"StartPage": "156", "EndPage": "174", "MedlinePgn": "156-174"}, "Abstract": {"AbstractText": ["Medicinal plants are a plentiful source of bioactive molecules with much structural diversity. In cancer treatment, molecules obtained from plants represent an attractive alternative to other treatments because several plant-derived compounds have exhibited lower toxicity and higher selectivity against cancer cells. In this review, we focus on the possible application of bioactive molecules obtained from plants against more primitive cell populations in cancers, cancer stem cells. Cancer stem cells are present in several kinds of tumors and are responsible for recurrences and metastases. Common anti-cancer drugs exhibit lower effectiveness against cancer stem cells because of their biological features. However, recently discovered natural phytometabolites exert cytotoxic effects on this rare population of cells in cancers. Therefore, this review presents the latest research on promising compounds from plants that can act as antitumor drugs and that mainly affect stem cell populations in cancers."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Bioqu\u00edmica, Universidade Federal de S\u00e3o Paulo (Campus S\u00e3o Paulo), S\u00e3o Paulo, Brazil."}], "LastName": "Torquato", "ForeName": "Heron F V", "Initials": "HF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Biotecnologia, Centro Universit\u00e1rio Univates, Rio Grande do Sul, Brazil."}], "LastName": "Goettert", "ForeName": "M\u00e1rcia I", "Initials": "MI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Bioqu\u00edmica, Universidade Federal de S\u00e3o Paulo (Campus S\u00e3o Paulo), S\u00e3o Paulo, Brazil;; Departamento de Ci\u00eancias Biol\u00f3gicas (Campus Diadema), Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "LastName": "Justo", "ForeName": "Giselle Z", "Initials": "GZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Bioqu\u00edmica, Universidade Federal de S\u00e3o Paulo (Campus S\u00e3o Paulo), S\u00e3o Paulo, Brazil;; Centro Interdisciplinar de Investiga\u00e7\u00e3o Bioqu\u00edmica, Universidade de Mogi das Cruzes, S\u00e3o Paulo, Brazil."}], "LastName": "Paredes-Gamero", "ForeName": "Edgar J", "Initials": "EJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Genomics", "NlmUniqueID": "100960527", "ISSNLinking": "1389-2029"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u2013674.", "ArticleIdList": ["21376230"]}, {"Citation": "Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A. Jr., Kinzler, K.W. Cancer genome landscapes. Science. 2013;339(6127):1546\u20131558.", "ArticleIdList": ["PMC3749880", "23539594"]}, {"Citation": "Holohan C., Van Schaeybroeck S., Longley D.B., Johnston P.G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer. 2013;13(10):714\u2013726.", "ArticleIdList": ["24060863"]}, {"Citation": "O'Connor M.L., Xiang D., Shigdar S., Macdonald J., Li Y., Wang T., Pu C., Wang Z., Qiao L., Duan W. Cancer stem cells: A contentious hypothesis now moving forward. Cancer Lett. 2014;344(2):180\u2013187.", "ArticleIdList": ["24333726"]}, {"Citation": "Martinez-Outschoorn U.E., Lin Z., Ko Y.H., Goldberg A.F., Flomenberg N., Wang C., Pavlides S., Pestell R.G., Howell A., Sotgia F., Lisanti M.P. Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle. 2011;10(15):2521\u20132528.", "ArticleIdList": ["PMC3180190", "21768775"]}, {"Citation": "Garraway L.A., Janne P.A. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov. 2012;2(3):214\u2013226.", "ArticleIdList": ["22585993"]}, {"Citation": "Vinogradov S., Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond.) 2012;7(4):597\u2013615.", "ArticleIdList": ["PMC3376090", "22471722"]}, {"Citation": "Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 2005;5(4):275\u2013284.", "ArticleIdList": ["15803154"]}, {"Citation": "Insan M.B., Jaitak V. New approaches to target cancer stem cells: current scenario. Mini Rev. Med. Chem. 2014;14(1):20\u201334.", "ArticleIdList": ["24195662"]}, {"Citation": "Paredes-Gamero E.J., Nogueira-Pedro A., Miranda A., Justo G.Z. Hematopoietic modulators as potential agents for the treatment of leukemia. Front. Biosci. (Elite Ed.) 2013;5:130\u2013140.", "ArticleIdList": ["23276976"]}, {"Citation": "Clarkson B.D. Review of recent studies of cellular proliferation in acute leukemia. Natl. Cancer Inst. Monogr. 1969;30:81\u2013120.", "ArticleIdList": ["5260445"]}, {"Citation": "Dick J.E. Stem cell concepts renew cancer research. Blood. 2008;112(13):4793\u20134807.", "ArticleIdList": ["19064739"]}, {"Citation": "Horton S.J., Huntly B.J. Recent advances in acute myeloid leukemia stem cell biology. Haematologica. 2012;97(7):966\u2013974.", "ArticleIdList": ["PMC3396664", "22511496"]}, {"Citation": "Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997;3(7):730\u2013737.", "ArticleIdList": ["9212098"]}, {"Citation": "Wicha M.S., Liu S., Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 2006;66(4):1883\u20131890.", "ArticleIdList": ["16488983"]}, {"Citation": "Shackleton M. Normal stem cells and cancer stem cells: similar and different. Semin. Cancer Biol. 2010;20(2):85\u201392.", "ArticleIdList": ["20435143"]}, {"Citation": "Bhatia M., Wang J.C., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA. 1997;94(10):5320\u20135325.", "ArticleIdList": ["PMC24676", "9144235"]}, {"Citation": "Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA. 2003;100(7):3983\u20133988.", "ArticleIdList": ["PMC153034", "12629218"]}, {"Citation": "Choi S.A., Wang K.C., Phi J.H., Lee J.Y., Park C.K., Park S.H., Kim S.K. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells. Cancer Lett. 2012;324(2):221\u2013230.", "ArticleIdList": ["22652175"]}, {"Citation": "Wei H.J., Yin T., Zhu Z., Shi P.F., Tian Y., Wang C.Y. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment. Hepatobiliary Pancreat. Dis. Int. 2011;10(14):428\u2013434.", "ArticleIdList": ["21813394"]}, {"Citation": "Ren F., Sheng W.Q., Du X. CD133: a cancer stem cells marker, is used in colorectal cancers. World J. Gastroenterol. 2013;19(17):2603\u20132611.", "ArticleIdList": ["PMC3645378", "23674867"]}, {"Citation": "Piao L.S., Hur W., Kim T.K., Hong S.W., Kim S.W., Choi J.E., Sung P.S., Song M.J., Lee B.C., Hwang D., Yoon S.K. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett. 2012;315(2):129\u2013137.", "ArticleIdList": ["22079466"]}, {"Citation": "Soner B.C., Aktug H., Acikgoz E., Duzagac F., Guven U., Ayla S., Cal C., Oktem G. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/ CD44+ prostate cancer stem cells by flavopiridol. Int. J. Mol. Med. 2014;34(5):1249\u20131256.", "ArticleIdList": ["PMC4199402", "25216351"]}, {"Citation": "Sarvi S., Mackinnon A.C., Avlonitis N., Bradley M., Rintoul R.C., Rassl D.M., Wang W., Forbes S.J., Gregory C.D., Sethi T. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res. 2014;74(5):1554\u20131565.", "ArticleIdList": ["24436149"]}, {"Citation": "Walters Haygood C.L., Arend R.C., Straughn J.M., Buchsbaum D.J. Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival? World J. Stem Cells. 2014;6(4):441\u2013447.", "ArticleIdList": ["PMC4172672", "25258665"]}, {"Citation": "Zinzi L., Contino M., Cantore M., Capparelli E., Leopoldo M., Colabufo N.A. ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Front. Pharmacol. 2014;5:163.", "ArticleIdList": ["PMC4091306", "25071581"]}, {"Citation": "Yamamoto M., Taguchi Y., Ito-Kureha T., Semba K., Yamaguchi N., Inoue J. NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat. Commun. 2013;4:2299.", "ArticleIdList": ["23934482"]}, {"Citation": "Takebe N., Miele L., Harris P.J., Jeong W., Bando H., Kahn M., Yang S.X., Ivy S.P. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat. Rev. Clin. Oncol. 2015;12(8):445\u2013464.", "ArticleIdList": ["PMC4520755", "25850553"]}, {"Citation": "Butler M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004;67(12):2141\u20132153.", "ArticleIdList": ["15620274"]}, {"Citation": "Newman D.J., Cragg G.M., Snader K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000;17(3):215\u2013234.", "ArticleIdList": ["10888010"]}, {"Citation": "Calixto J.B. Twenty-five years of research on medicinal plants in Latin America: a personal view. J. Ethnopharmacol. 2005;100(1-2):131\u2013134.", "ArticleIdList": ["16006081"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75(3):311\u2013335.", "ArticleIdList": ["PMC3721181", "22316239"]}, {"Citation": "Basmadjian C., Zhao Q., Bentouhami E., Djehal A., Nebigil C.G., Johnson R.A., Serova M., de Gramont A., Faivre S., Raymond E., Desaubry L.G. Cancer wars: natural products strike back. Front Chem. 2014;2:20.", "ArticleIdList": ["PMC4013484", "24822174"]}, {"Citation": "Thomas C.J., Rahier N.J., Hecht S.M. Camptothecin: current perspectives. Bioorg. Med. Chem. 2004;12(7):1585\u20131604.", "ArticleIdList": ["15028252"]}, {"Citation": "Dias D.A., Urban S., Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2(2):303\u2013336.", "ArticleIdList": ["PMC3901206", "24957513"]}, {"Citation": "Ruttala H.B., Ko Y.T. Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy. Pharm. Res. 2015;32(3):1002\u20131016.", "ArticleIdList": ["25213777"]}, {"Citation": "Borst P. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? Open Biol. 2012;2(5):120066.", "ArticleIdList": ["PMC3376736", "22724067"]}, {"Citation": "Efthymiou A.G., Chen G., Rao M., Boehm M. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. Expert Opin. Biol. Ther. 2014;14(9):1333\u20131344.", "ArticleIdList": ["PMC6469346", "24881868"]}, {"Citation": "Yoo Y.D., Kwon Y.T. Molecular mechanisms controlling asymmetric and symmetric self-renewal of cancer stem cells. J. Anal. Sci. Technol. 2015;6(1):28.", "ArticleIdList": ["PMC4607713", "26495157"]}, {"Citation": "Moitra K., Lou H., Dean M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin. Pharmacol. Ther. 2011;89(4):491\u2013502.", "ArticleIdList": ["21368752"]}, {"Citation": "Heo H.R., Chen L., An B., Kim K.S., Ji J., Hong S.H. Hormonal regulation of hematopoietic stem cells and their niche: a focus on estrogen. Int. J. Stem Cells. 2015;8(1):18\u201323.", "ArticleIdList": ["PMC4445706", "26019751"]}, {"Citation": "Scharenberg C.W., Harkey M.A., Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002;99(2):507\u2013512.", "ArticleIdList": ["11781231"]}, {"Citation": "Dean M. ABC transporters, drug resistance, and cancer stem cells. J. Mammary Gland Biol. Neoplasia. 2009;14(1):3\u20139.", "ArticleIdList": ["19224345"]}, {"Citation": "Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer. 2002;2(1):48\u201358.", "ArticleIdList": ["11902585"]}, {"Citation": "Fletcher J.I., Haber M., Henderson M.J., Norris M.D. ABC transporters in cancer: more than just drug efflux pumps. Nat. Rev. Cancer. 2010;10(2):147\u2013156.", "ArticleIdList": ["20075923"]}, {"Citation": "Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996;183(4):1797\u20131806.", "ArticleIdList": ["PMC2192511", "8666936"]}, {"Citation": "Petriz J. 2013."}, {"Citation": "Kaminski W.E., Piehler A., Wenzel J.J. ABC A-subfamily transporters: structure, function and disease. Biochim. Biophys. Acta. 2006;1762(5):510\u2013524.", "ArticleIdList": ["16540294"]}, {"Citation": "Gatti L., Beretta G.L., Cossa G., Zunino F., Perego P. ABC transporters as potential targets for modulation of drug resistance. Mini Rev. Med. Chem. 2009;9(9):1102\u20131112.", "ArticleIdList": ["19689406"]}, {"Citation": "Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156\u20131166.", "ArticleIdList": ["11435397"]}, {"Citation": "Angelastro J.M., Lame M.W. Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol. Cancer Res. 2010;8(8):1105\u20131115.", "ArticleIdList": ["PMC2923683", "20663862"]}, {"Citation": "Gong W., Wang Z., Wan Y., Shi L., Zhou Y. Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells. Neuroreport. 2014;25(8):625\u2013632.", "ArticleIdList": ["24781949"]}, {"Citation": "Leccia F., Del Vecchio L., Mariotti E., Di Noto R., Morel A.P., Puisieux A., Salvatore F., Ansieau S. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Mol. Cancer. 2014;13:213.", "ArticleIdList": ["PMC4176869", "25216750"]}, {"Citation": "Grimm M., Krimmel M., Polligkeit J., Alexander D., Munz A., Kluba S., Keutel C., Hoffmann J., Reinert S., Hoefert S. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. Eur. J. Cancer. 2012;48(17):3186\u20133197.", "ArticleIdList": ["22784549"]}, {"Citation": "Hung T.H., Hsu S.C., Cheng C.Y., Choo K.B., Tseng C.P., Chen T.C., Lan Y.W., Huang T.T., Lai H.C., Chen C.M., Chong K.Y. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/beta-catenin pathway. Oncotarget. 2014;5(23):12273\u201312290.", "ArticleIdList": ["PMC4322984", "25401518"]}, {"Citation": "Hosokawa Y., Takahashi H., Inoue A., Kawabe Y., Funahashi Y., Kameda K., Sugimoto K., Yano H., Harada H., Kohno S., Ohue S., Ohnishi T., Tanaka J. Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2. Biochim. Biophys. Acta. 2015;1850(6):1197\u20131205.", "ArticleIdList": ["25644290"]}, {"Citation": "Tan B., Piwnica-Worms D., Ratner L. Multidrug resistance transporters and modulation. Curr. Opin. Oncol. 2000;12(5):450\u2013458.", "ArticleIdList": ["10975553"]}, {"Citation": "Shukla S., Ohnuma S., Ambudkar S.V. Improving cancer chemotherapy with modulators of ABC drug transporters. Curr. Drug Targets. 2011;12(5):621\u2013630.", "ArticleIdList": ["PMC3401946", "21039338"]}, {"Citation": "Kathawala R.J., Gupta P., Ashby C.R. Jr., Chen, Z.S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist. Updat. 2015;18:1\u201317.", "ArticleIdList": ["25554624"]}, {"Citation": "Wu C.P., Calcagno A.M., Ambudkar S.V. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr. Mol. Pharmacol. 2008;1(2):93\u2013105.", "ArticleIdList": ["PMC2600768", "19079736"]}, {"Citation": "Cort A., Ozben T. Natural product modulators to overcome multidrug resistance in cancer. Nutr. Cancer. 2015;67(3):411\u2013423.", "ArticleIdList": ["25649862"]}, {"Citation": "Tran V.H., Marks D., Duke R.K., Bebawy M., Duke C.C., Roufogalis B.D. Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions. Nutr. Cancer. 2011;63(3):435\u2013443.", "ArticleIdList": ["21462089"]}, {"Citation": "Bansal T., Jaggi M., Khar R.K., Talegaonkar S. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J. Pharm. Pharm. Sci. 2009;12(1):46\u201378.", "ArticleIdList": ["19470292"]}, {"Citation": "de Pace R.C., Liu X., Sun M., Nie S., Zhang J., Cai Q., Gao W., Pan X., Fan Z., Wang S. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J. Liposome Res. 2013;23(3):187\u2013196.", "ArticleIdList": ["23600473"]}, {"Citation": "Jiang L., Tao C., He A., He X. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate. World J. Surg. Oncol. 2014;12:383.", "ArticleIdList": ["PMC4300611", "25510179"]}, {"Citation": "Shen X., Zhang Y., Feng Y., Zhang L., Li J., Xie Y.A., Luo X. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. Int. J. Oncol. 2014;44(3):791\u2013796.", "ArticleIdList": ["24402647"]}, {"Citation": "Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011;82(12):1807\u20131821.", "ArticleIdList": ["PMC4082721", "21827739"]}, {"Citation": "Zhang Y., Wang S.X., Ma J.W., Li H.Y., Ye J.C., Xie S.M., Du B., Zhong X.Y. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition. J. Neurooncol. 2015;121(1):41\u201352.", "ArticleIdList": ["25173233"]}, {"Citation": "Farabegoli F., Papi A., Bartolini G., Ostan R., Orlandi M. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. 2010;17(5):356\u2013362.", "ArticleIdList": ["20149610"]}, {"Citation": "Qian F., Wei D., Zhang Q., Yang S. Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells. Biomed. Pharmacother. 2005;59(3):64\u201369.", "ArticleIdList": ["15795098"]}, {"Citation": "Sreejayan Rao M.N. Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 1997;49(1):105\u2013107.", "ArticleIdList": ["9120760"]}, {"Citation": "Nagabhushan M., Amonkar A.J., Bhide S.V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol. 1987;25(7):545\u2013547.", "ArticleIdList": ["3623345"]}, {"Citation": "Jurenka J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 2009;14(2):141\u2013153.", "ArticleIdList": ["19594223"]}, {"Citation": "Jiang M., Huang O., Zhang X., Xie Z., Shen A., Liu H., Geng M., Shen K. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules. 2013;18(1):701\u2013720.", "ArticleIdList": ["PMC6269686", "23299550"]}, {"Citation": "Duarte V.M., Han E., Veena M.S., Salvado A., Suh J.D., Liang L.J., Faull K.F., Srivatsan E.S., Wang M.B. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NF-kappaB pathway. Mol. Cancer Ther. 2010;9(10):2665\u20132675.", "ArticleIdList": ["PMC3004013", "20937593"]}, {"Citation": "Sadzuka Y., Nagamine M., Toyooka T., Ibuki Y., Sonobe T. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int. J. Pharm. 2012;432(1-2):42\u201349.", "ArticleIdList": ["22569233"]}, {"Citation": "Everett P.C., Meyers J.A., Makkinje A., Rabbi M., Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am. J. Hematol. 2007;82(1):23\u201330.", "ArticleIdList": ["16947318"]}, {"Citation": "Chearwae W., Anuchapreeda S., Nandigama K., Ambudkar S.V., Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem. Pharmacol. 2004;68(10):2043\u20132052.", "ArticleIdList": ["15476675"]}, {"Citation": "Chearwae W., Shukla S., Limtrakul P., Ambudkar S.V. Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol. Cancer Ther. 2006;5(8):1995\u20132006.", "ArticleIdList": ["16928820"]}, {"Citation": "Choi B.H., Kim C.G., Lim Y., Shin S.Y., Lee Y.H. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 2008;259(1):111\u2013118.", "ArticleIdList": ["18006147"]}, {"Citation": "Patil R.H., Babu R.L., Naveen Kumar M., Kiran Kumar K.M., Hegde S.M., Nagesh R., Ramesh G.T., Sharma S.C. Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial Cells. Inflammation. 2015 In Press.", "ArticleIdList": ["26276128"]}, {"Citation": "Patil R.H., Babu R.L., Naveen Kumar M., Kiran Kumar K.M., Hegde S.M., Ramesh G.T., Chidananda Sharma S. Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells. Mol. Cell. Biochem. 2015;403(1-2):95\u2013106.", "ArticleIdList": ["25666088"]}, {"Citation": "Romanova D., Vachalkova A., Cipak L., Ovesna Z., Rauko P. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma. 2001;48(2):104\u2013107.", "ArticleIdList": ["11478688"]}, {"Citation": "Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Int. J. Oncol. 2007;30(1):233\u2013245. [review].", "ArticleIdList": ["17143534"]}, {"Citation": "Hashemi M., Long N. M.; Entezari, M.; Nafisi, S.; Nowroozii, H. Anti-mutagenic and pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells. Acta Med. Iran. 2010;48(5):283\u2013288.", "ArticleIdList": ["21287458"]}, {"Citation": "Saeed M., Kadioglu O., Khalid H., Sugimoto Y., Efferth T. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. J. Nutr. Biochem. 2015;26(1):44\u201356.", "ArticleIdList": ["25459885"]}, {"Citation": "Pang B., Zhao L.H., Zhou Q., Zhao T.Y., Wang H., Gu C.J., Tong X.L. Application of berberine on treating type 2 diabetes mellitus. 2015.", "ArticleIdList": ["PMC4377488", "25861268"]}, {"Citation": "Ahmed T., Gilani A.U., Abdollahi M., Daglia M., Nabavi S.F., Nabavi S.M. Berberine and neurodegeneration: A review of literature. Pharmacol. Rep. 2015;67(5):970\u2013979.", "ArticleIdList": ["26398393"]}, {"Citation": "Kumar A. Ekavali; Chopra, K.; Mukherjee, M.; Pottabathini, R.; Dhull, D.K. Current knowledge and pharmacological profile of berberine: An update. Eur. J. Pharmacol. 2015;761:288\u2013297.", "ArticleIdList": ["26092760"]}, {"Citation": "Lu B., Hu M., Liu K., Peng J. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol. In Vitro. 2010;24(6):1482\u20131490.", "ArticleIdList": ["20656010"]}, {"Citation": "Park S.H., Sung J.H., Chung N. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Mol. Cell. Biochem. 2014;394(1-2):209\u2013215.", "ArticleIdList": ["24894821"]}, {"Citation": "Ma X., Zhou J., Zhang C.X., Li X.Y., Li N., Ju R.J., Shi J.F., Sun M.G., Zhao W.Y., Mu L.M., Yan Y., Lu W.L. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013;34(18):4452\u20134465.", "ArticleIdList": ["23518403"]}, {"Citation": "Shim S.H. 20S proteasome inhibitory activity of flavonoids isolated from Spatholobus suberectus. Phytother. Res. 2011;25(4):615\u2013618.", "ArticleIdList": ["21104764"]}, {"Citation": "Jung S.K., Lee M.H. Lim do, Y.; Kim, J.E.; Singh, P.; Lee, S.Y.; Jeong, C.H.; Lim, T.G.; Chen, H.; Chi, Y.I.; Kundu, J.K.; Lee, N.H.; Lee, C.C.; Cho, Y.Y.; Bode, A.M.; Lee, K.W.; Dong, Z. Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. J. Biol. Chem. 2014;289(52):35839\u201335848.", "ArticleIdList": ["PMC4276852", "25368326"]}, {"Citation": "Fessler E., Dijkgraaf F.E., De Sousa E., Melo F., Medema J.P. Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame? Cancer Lett. 2013;341(1):97\u2013104.", "ArticleIdList": ["23089245"]}, {"Citation": "Zheng H., Li Y., Wang Y., Zhao H., Zhang J., Chai H., Tang T., Yue J., Guo A.M., Yang J. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion. Toxicol. Appl. Pharmacol. 2014;280(1):10\u201320.", "ArticleIdList": ["25094029"]}, {"Citation": "Khramtsov A.I., Khramtsova G.F., Tretiakova M., Huo D., Olopade O.I., Goss K.H. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 2010;176(6):2911\u20132920.", "ArticleIdList": ["PMC2877852", "20395444"]}, {"Citation": "Wang J., Xiao L.D., He G.P., Ullah S., De Bellis A. Factors contributing to caregiver burden in dementia in a country without formal caregiver support. Aging Ment. Health. 2014;18(8):986\u2013996.", "ArticleIdList": ["24679066"]}, {"Citation": "Zeino M., Paulsen M.S., Zehl M., Urban E., Kopp B., Efferth T. Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids. Biochem. Pharmacol. 2015;93(1):11\u201324.", "ArticleIdList": ["25451686"]}, {"Citation": "Callies O., Sanchez-Canete M.P., Gamarro F., Jimenez I.A., Castanys S., Bazzocchi I.L. Restoration of Chemosensitivity in P-Glycoprotein-Dependent Multidrug-Resistant Cells by Dihydro-beta-agarofuran Sesquiterpenes from Celastrus vulcanicola. J. Nat. Prod. 2015;78(4):736\u2013745.", "ArticleIdList": ["25695368"]}, {"Citation": "Su S., Cheng X., Wink M. Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells. Phytomedicine. 2015;22(2):301\u2013307.", "ArticleIdList": ["25765837"]}, {"Citation": "Gu Y.Y., Liu L.P., Qin J., Zhang M., Chen Y., Wang D., Li Z., Tang J.Z., Mo S.L. Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro. Fitoterapia. 2014;94:21\u201328.", "ArticleIdList": ["24468191"]}, {"Citation": "Maliyakkal N., Appadath Beeran A., Balaji S.A., Udupa N., Ranganath Pai S., Rangarajan A. Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer. Integr. Cancer Ther. 2015;14(2):156\u2013171.", "ArticleIdList": ["25549922"]}, {"Citation": "Kahn M. Can we safely target the WNT pathway? Nat. Rev. Drug Discov. 2014;13(7):513\u2013532.", "ArticleIdList": ["PMC4426976", "24981364"]}, {"Citation": "Niehrs C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 2012;13(12):767\u2013779.", "ArticleIdList": ["23151663"]}, {"Citation": "Holland J.D., Klaus A., Garratt A.N., Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol. 2013;25(2):254\u2013264.", "ArticleIdList": ["23347562"]}, {"Citation": "Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R. 3rd, Nusse, R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003;423(6938):448\u2013452.", "ArticleIdList": ["12717451"]}, {"Citation": "Banziger C., Soldini D., Schutt C., Zipperlen P., Hausmann G., Basler K. Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell. 2006;125(3):509\u2013522.", "ArticleIdList": ["16678095"]}, {"Citation": "Hofmann K. A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem. Sci. 2000;25(3):111\u2013112.", "ArticleIdList": ["10694878"]}, {"Citation": "Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002;108(6):837\u2013847.", "ArticleIdList": ["11955436"]}, {"Citation": "Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469\u2013480.", "ArticleIdList": ["17081971"]}, {"Citation": "Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149(6):1192\u20131205.", "ArticleIdList": ["22682243"]}, {"Citation": "Gao C., Chen Y.G. Dishevelled: The hub of Wnt signaling. Cell. Signal. 2010;22(5):717\u2013727.", "ArticleIdList": ["20006983"]}, {"Citation": "Wend P., Holland J.D., Ziebold U., Birchmeier W. Wnt signaling in stem and cancer stem cells. Semin. Cell Dev. Biol. 2010;21(8):855\u2013863.", "ArticleIdList": ["20837152"]}, {"Citation": "MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell. 2009;17(1):9\u201326.", "ArticleIdList": ["PMC2861485", "19619488"]}, {"Citation": "Polakis P. Drugging Wnt signalling in cancer. EMBO J. 2012;31(12):2737\u20132746.", "ArticleIdList": ["PMC3380214", "22617421"]}, {"Citation": "Scheel S.K., Porzner M., Pfeiffer S., Ormanns S., Kirchner T., Jung A. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer. 2010;10:413.", "ArticleIdList": ["PMC2928794", "20696052"]}, {"Citation": "Major M.B., Camp N.D., Berndt J.D., Yi X., Goldenberg S.J., Hubbert C., Biechele T.L., Gingras A.C., Zheng N., Maccoss M.J., Angers S., Moon R.T. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science. 2007;316(5827):1043\u20131046.", "ArticleIdList": ["17510365"]}, {"Citation": "Moyes K.W., Sip C.G., Obenza W., Yang E., Horst C., Welikson R.E., Hauschka S.D., Folch A., Laflamme M.A. Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. Stem Cells Dev. 2013;22(16):2315\u20132325.", "ArticleIdList": ["PMC3732016", "23517131"]}, {"Citation": "Qin L., Yin Y.T., Zheng F.J., Peng L.X., Yang C.F., Bao Y.N., Liang Y.Y., Li X.J., Xiang Y.Q., Sun R., Li A.H., Zou R.H., Pei X.Q., Huang B.J., Kang T.B., Liao D.F., Zeng Y.X., Williams B.O., Qian C.N. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Oncotarget. 2015;6(12):10239\u201310252.", "ArticleIdList": ["PMC4496352", "25823923"]}, {"Citation": "Zhang Y., Zhang X., Huang J., Dong Q. Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines. Med. Oncol. 2015;32(5):157.", "ArticleIdList": ["25840791"]}, {"Citation": "Mao J., Fan S., Ma W., Fan P., Wang B., Zhang J., Wang H., Tang B., Zhang Q., Yu X., Wang L., Song B., Li L. Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:e1039.", "ArticleIdList": ["PMC4040703", "24481453"]}, {"Citation": "Ashihara E., Takada T., Maekawa T. Targeting the canonical Wnt/beta-catenin pathway in hematological malignancies. Cancer Sci. 2015;106(6):665\u2013671.", "ArticleIdList": ["PMC4471797", "25788321"]}, {"Citation": "Mahady G.B., Pendland S.L., Yun G.S., Lu Z.Z., Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res. 2003;23(5A):3699\u20133702.", "ArticleIdList": ["PMC3761965", "14666666"]}, {"Citation": "Moon M., Kim H.G., Choi J.G., Oh H., Lee P.K., Ha S.K., Kim S.Y., Park Y., Huh Y., Oh M.S. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia. Biochem. Biophys. Res. Commun. 2014;449(1):8\u201313.", "ArticleIdList": ["24796668"]}, {"Citation": "Shigeishi H., Biddle A., Gammon L., Emich H., Rodini C.O., Gemenetzidis E., Fazil B., Sugiyama M., Kamata N., Mackenzie I.C. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3beta influenced by CD44 and RHAMM. Stem Cells. 2013;31(10):2073\u20132083.", "ArticleIdList": ["23649588"]}, {"Citation": "Wu C.H., Hong B.H., Ho C.T., Yen G.C. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene. J. Agric. Food Chem. 2015;63(9):2432\u20132441.", "ArticleIdList": ["25686711"]}, {"Citation": "Khoo B.Y., Chua S.L., Balaram P. Apoptotic effects of chrysin in human cancer cell lines. Int. J. Mol. Sci. 2010;11(5):2188\u20132199.", "ArticleIdList": ["PMC2885101", "20559509"]}, {"Citation": "Yang X.H., Zheng X., Cao J.G., Xiang H.L., Liu F., Lv Y. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J. Gastroenterol. 2010;16(27):3385\u20133393.", "ArticleIdList": ["PMC2904884", "20632440"]}, {"Citation": "Quan M.F., Xiao L.H., Liu Z.H., Guo H., Ren K.Q., Liu F., Cao J.G., Deng X.Y. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of beta-catenin. World J. Gastroenterol. 2013;19(43):7680\u20137695.", "ArticleIdList": ["PMC3837267", "24431896"]}, {"Citation": "Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 1999;96(10):5522\u20135527.", "ArticleIdList": ["PMC21892", "10318916"]}, {"Citation": "He G., Cao X., He M., Sheng X., Wu Y., Ai X. Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line. Oncol. Lett. 2014;7(6):2023\u20132028.", "ArticleIdList": ["PMC4049684", "24932283"]}, {"Citation": "He M., Cao X.C., He G.C., Sheng X.F., Ai X.H., Wu Y.H. Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist. Oncol. Lett. 2014;7(5):1625\u20131631.", "ArticleIdList": ["PMC3997701", "24765190"]}, {"Citation": "Das S., Das D.K. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents Cardiovasc. Drug Discov. 2007;2(2):133\u2013138.", "ArticleIdList": ["18221111"]}, {"Citation": "Lekli I., Ray D., Das D.K. Longevity nutrients resveratrol, wines and grapes. Genes Nutr. 2010;5(1):55\u201360.", "ArticleIdList": ["PMC2820197", "19730919"]}, {"Citation": "Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007;224(3):274\u2013283.", "ArticleIdList": ["PMC2083123", "17306316"]}, {"Citation": "Chan M.M. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem. Pharmacol. 2002;63(2):99\u2013104.", "ArticleIdList": ["11841782"]}, {"Citation": "Shankar S., Nall D., Tang S.N., Meeker D., Passarini J., Sharma J., Srivastava R.K. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 2011;6(1):e16530.", "ArticleIdList": ["PMC3031576", "21304978"]}, {"Citation": "Fu Y., Chang H., Peng X., Bai Q., Yi L., Zhou Y., Zhu J., Mi M. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS One. 2014;9(7):e102535.", "ArticleIdList": ["PMC4113212", "25068516"]}, {"Citation": "Tsai J.H., Hsu L.S., Lin C.L., Hong H.M., Pan M.H., Way T.D., Chen W.J. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/beta-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicol. Appl. Pharmacol. 2013;272(3):746\u2013756.", "ArticleIdList": ["23921149"]}, {"Citation": "Boddupalli S., Mein J.R., Lakkanna S., James D.R. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E. Front. Genet. 2012;3:7.", "ArticleIdList": ["PMC3264924", "22303412"]}, {"Citation": "Abe N., Hou D.X., Munemasa S., Murata Y., Nakamura Y. Nuclear factor-kappaB sensitizes to benzyl isothiocyanate-induced antiproliferation in p53-deficient colorectal cancer cells. 2014;3 e1534.", "ArticleIdList": ["PMC4260753", "25412312"]}, {"Citation": "Lin L.C., Yeh C.T., Kuo C.C., Lee C.M., Yen G.C., Wang L.S., Wu C.H., Yang W.C., Wu A.T. Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/beta-catenin function. J. Agric. Food Chem. 2012;60(28):7031\u20137039.", "ArticleIdList": ["22708678"]}, {"Citation": "Wilken R., Veena M.S., Wang M.B., Srivatsan E.S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer. 2011;10:12.", "ArticleIdList": ["PMC3055228", "21299897"]}, {"Citation": "Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M.S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010;122(3):777\u2013785.", "ArticleIdList": ["PMC3039120", "19898931"]}, {"Citation": "Leow P.C., Tian Q., Ong Z.Y., Yang Z., Ee P.L. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest. New Drugs. 2010;28(6):766\u2013782.", "ArticleIdList": ["19730790"]}, {"Citation": "Xu M.X., Zhao L., Deng C., Yang L., Wang Y., Guo T., Li L., Lin J., Zhang L. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. Int. J. Oncol. 2013;43(6):1951\u20131959.", "ArticleIdList": ["24064724"]}, {"Citation": "Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 1990;345(6277):686\u2013692.", "ArticleIdList": ["1972777"]}, {"Citation": "Zhang Z.N., Chung S.K., Xu Z., Xu Y. Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells. 2014;32(1):157\u2013165.", "ArticleIdList": ["PMC3947311", "24038750"]}, {"Citation": "Yun J.H., Park Y.G., Lee K.M., Kim J., Nho C.W. Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3beta activation in NCCIT cells. Mol. Nutr. Food Res. 2015;59(6):1053\u20131062.", "ArticleIdList": ["25755051"]}, {"Citation": "Chesire D.R., Isaacs W.B. Beta-catenin signaling in prostate cancer: an early perspective. Endocr. Relat. Cancer. 2003;10(4):537\u2013560.", "ArticleIdList": ["14713266"]}, {"Citation": "Verras M., Sun Z. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett. 2006;237(1):22\u201332.", "ArticleIdList": ["16023783"]}, {"Citation": "Kypta R.M., Waxman J. Wnt/beta-catenin signalling in prostate cancer. Nat. Rev. Urol. 2012;9(8):418\u2013428.", "ArticleIdList": ["22710668"]}, {"Citation": "Mahmoud A.M., Yang W., Bosland M.C. Soy isoflavones and prostate cancer: a review of molecular mechanisms. J. Steroid Biochem. Mol. Biol. 2014;140:116\u2013132.", "ArticleIdList": ["PMC3962012", "24373791"]}, {"Citation": "An S.M., Ding Q.P., Li L.S. Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways. Acta Pharmacol. Sin. 2013;34(6):777\u2013783.", "ArticleIdList": ["PMC4002899", "23708555"]}, {"Citation": "Yao C.J., Lai G.M., Yeh C.T., Lai M.T., Shih P.H., Chao W.J., Whang-Peng J., Chuang S.E., Lai T.Y. Accompanied with Suppression of Wnt/ beta -Catenin Signaling and Apoptosis Induction. EvidBased Complement. Alternat. Med. 2013. 146136.", "ArticleIdList": ["PMC3638590", "23662112"]}, {"Citation": "Liu J., Sato C., Cerletti M., Wagers A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr. Top. Dev. Biol. 2010;92:367\u2013409.", "ArticleIdList": ["20816402"]}, {"Citation": "Schwanbeck R. The role of epigenetic mechanisms in Notch signaling during development. J. Cell. Physiol. 2015;230(5):969\u2013981.", "ArticleIdList": ["25336183"]}, {"Citation": "Wang J., Sullenger B.A., Rich J.N. Notch signaling in cancer stem cells. Adv. Exp. Med. Biol. 2012;727:174\u2013185.", "ArticleIdList": ["22399347"]}, {"Citation": "Koch U., Radtke F. Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 2007;64(21):2746\u20132762.", "ArticleIdList": ["PMC11136344", "17687513"]}, {"Citation": "Bolos V., Blanco M., Medina V., Aparicio G., Diaz-Prado S., Grande E. Notch signalling in cancer stem cells. Clin. Transl. Oncol. 2009;11(1):11\u201319.", "ArticleIdList": ["19155199"]}, {"Citation": "Wang H., Zang C., Liu X.S., Aster J.C. The role of Notch receptors in transcriptional regulation. J. Cell. Physiol. 2015;230(5):982\u2013988.", "ArticleIdList": ["PMC4442318", "25418913"]}, {"Citation": "Pursglove S.E., Mackay J.P. CSL: a notch above the rest. Int. J. Biochem. Cell Biol. 2005;37(12):2472\u20132477.", "ArticleIdList": ["16095948"]}, {"Citation": "Espinoza I., Miele L. Notch inhibitors for cancer treatment. Pharmacol. Ther. 2013;139(2):95\u2013110.", "ArticleIdList": ["PMC3732476", "23458608"]}, {"Citation": "Andersson E.R., Lendahl U. Therapeutic modulation of Notch signalling--are we there yet? Nat. Rev. Drug Discov. 2014;13(5):357\u2013378.", "ArticleIdList": ["24781550"]}, {"Citation": "Gupta-Rossi N., Le Bail O., Gonen H., Brou C., Logeat F., Six E., Ciechanover A., Israel A. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 2001;276(37):34371\u201334378.", "ArticleIdList": ["11425854"]}, {"Citation": "Tosello V., Ferrando A.A. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Ther. Adv. Hematol. 2013;4(3):199\u2013210.", "ArticleIdList": ["PMC3666445", "23730497"]}, {"Citation": "Hassan K.A., Wang L., Korkaya H., Chen G., Maillard I., Beer D.G., Kalemkerian G.P., Wicha M.S. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin. Cancer Res. 2013;19(8):1972\u20131980.", "ArticleIdList": ["PMC3630232", "23444212"]}, {"Citation": "Bao B., Wang Z., Ali S., Kong D., Li Y., Ahmad A., Banerjee S., Azmi A.S., Miele L., Sarkar F.H. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011;307(1):26\u201336.", "ArticleIdList": ["PMC3104092", "21463919"]}, {"Citation": "Humphrey P.A. Gleason grading and prognostic factors in carcinoma of the prostate. Mod. Pathol. 2004;17(3):292\u2013306.", "ArticleIdList": ["14976540"]}, {"Citation": "Carvalho F.L., Simons B.W., Eberhart C.G., Berman D.M. Notch signaling in prostate cancer: a moving target. Prostate. 2014;74(9):933\u2013945.", "ArticleIdList": ["PMC4323172", "24737393"]}, {"Citation": "Ling H., Sylvestre J.R., Jolicoeur P. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene. 2010;29(32):4543\u20134554.", "ArticleIdList": ["20562911"]}, {"Citation": "Ponnurangam S., Mammen J.M., Ramalingam S., He Z., Zhang Y., Umar S., Subramaniam D., Anant S. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol. Cancer Ther. 2012;11(4):963\u2013972.", "ArticleIdList": ["PMC3324630", "22319203"]}, {"Citation": "Kaushik G., Venugopal A., Ramamoorthy P., Standing D., Subramaniam D., Umar S., Jensen R.A., Anant S., Mammen J.M. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol. Carcinog. 2015;54(12):1710\u20131721.", "ArticleIdList": ["PMC4776032", "25491779"]}, {"Citation": "Ma L., Mao R., Shen K., Zheng Y., Li Y., Liu J., Ni L. Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits. Biochem. Biophys. Res. Commun. 2014;450(1):353\u2013359.", "ArticleIdList": ["24944018"]}, {"Citation": "Yan B., Liu L., Zhao Y., Xiu L.J., Sun D.Z., Liu X., Lu Y., Shi J., Zhang Y.C., Li Y.J., Wang X.W., Zhou Y.Q., Feng S.H., Lv C., Wei P.K., Qin Z.F. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J. Gastroenterol. 2014;20(36):13105\u201313118.", "ArticleIdList": ["PMC4177489", "25278704"]}, {"Citation": "Ray A., Vasudevan S., Sengupta S. 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death. PLoS One. 2015;10(9):e0137614.", "ArticleIdList": ["PMC4565635", "26355461"]}, {"Citation": "Lee S.H., Nam H.J., Kang H.J., Kwon H.W., Lim Y.C. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. Eur. J. Cancer. 2013;49(15):3210\u20133218.", "ArticleIdList": ["23876835"]}, {"Citation": "McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 2003;53:1\u2013114.", "ArticleIdList": ["12509125"]}, {"Citation": "Van Den Brink G.R., Peppelenbosch M.P. Expression of hedgehog pathway components in the adult colon. Gastroenterology. 2006;130(2):619.", "ArticleIdList": ["16472622"]}, {"Citation": "Wicking C., McGlinn E. The role of hedgehog signalling in tumorigenesis. Cancer Lett. 2001;173(1):1\u20137.", "ArticleIdList": ["11578802"]}, {"Citation": "Ehtesham M., Sarangi A., Valadez J.G., Chanthaphaychith S., Becher M.W., Abel T.W., Thompson R.C., Cooper M.K. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene. 2007;26(39):5752\u20135761.", "ArticleIdList": ["17353902"]}, {"Citation": "Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. Hedgehog-Gli1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007;17(2):165\u2013172.", "ArticleIdList": ["PMC1855204", "17196391"]}, {"Citation": "Peacock C.D., Wang Q., Gesell G.S., Corcoran-Schwartz I.M., Jones E., Kim J., Devereux W.L., Rhodes J.T., Huff C.A., Beachy P.A., Watkins D.N., Matsui W. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc. Natl. Acad. Sci. USA. 2007;104(10):4048\u20134053.", "ArticleIdList": ["PMC1805487", "17360475"]}, {"Citation": "Dierks C., Beigi R., Guo G.R., Zirlik K., Stegert M.R., Manley P., Trussell C., Schmitt-Graeff A., Landwerlin K., Veelken H., Warmuth M. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008;14(3):238\u2013249.", "ArticleIdList": ["18772113"]}, {"Citation": "Varnat F., Duquet A., Malerba M., Zbinden M., Mas C., Gervaz P., Ruiz i Altaba A. Human colon cancer epithelial cells harbour active Hedgehog-Gli signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med. 2009;1(6-7):338\u2013351.", "ArticleIdList": ["PMC3378144", "20049737"]}, {"Citation": "Zhao C., Chen A., Jamieson C.H., Fereshteh M., Abrahamsson A., Blum J., Kwon H.Y., Kim J., Chute J.P., Rizzieri D., Munchhof M., VanArsdale T., Beachy P.A., Reya T. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458(7239):776\u2013779.", "ArticleIdList": ["PMC2946231", "19169242"]}, {"Citation": "Song Z., Yue W., Wei B., Wang N., Li T., Guan L., Shi S., Zeng Q., Pei X., Chen L. Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One. 2011;6(3):e17687.", "ArticleIdList": ["PMC3048871", "21394208"]}, {"Citation": "Takebe N., Harris P.J., Warren R.Q., Ivy S.P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 2011;8(2):97\u2013106.", "ArticleIdList": ["21151206"]}, {"Citation": "Takebe N., Warren R.Q., Ivy S.P. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res. 2011;13(3):211.", "ArticleIdList": ["PMC3218933", "21672282"]}, {"Citation": "Babashah S., Sadeghizadeh M., Hajifathali A., Tavirani M.R., Zomorod M.S., Ghadiani M., Soleimani M. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells. Int. J. Cancer. 2013;133(3):579\u2013589.", "ArticleIdList": ["23341351"]}, {"Citation": "Batsaikhan B.E., Yoshikawa K., Kurita N., Iwata T., Takasu C., Kashihara H., Shimada M. Cyclopamine decreased the expression of Sonic Hedgehog and its downstream genes in colon cancer stem cells. Anticancer Res. 2014;34(11):6339\u20136344.", "ArticleIdList": ["25368233"]}, {"Citation": "Memmi E.M., Sanarico A.G., Giacobbe A., Peschiaroli A., Frezza V., Cicalese A., Pisati F., Tosoni D., Zhou H., Tonon G., Antonov A., Melino G., Pelicci P.G., Bernassola F. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. USA. 2015;112(1):3499\u20133504.", "ArticleIdList": ["PMC4372004", "25739959"]}, {"Citation": "Sadarangani A., Pineda G., Lennon K.M., Chun H.J., Shih A., Schairer A.E., Court A.C., Goff D.J., Prashad S.L., Geron I., Wall R., McPherson J.D., Moore R.A., Pu M., Bao L., Jackson-Fisher A., Munchhof M., VanArsdale T., Reya T., Morris S.R., Minden M.D., Messer K., Mikkola H.K., Marra M.A., Hudson T.J., Jamieson C.H. GLI2 inhibition abrogates human leukemia stem cell dormancy. J. Transl. Med. 2015;13:98.", "ArticleIdList": ["PMC4414375", "25889765"]}, {"Citation": "Cochrane C.R., Szczepny A., Watkins D.N., Cain J.E. Hedgehog Signaling in the Maintenance of Cancer Stem Cells. Cancers (Basel) 2015;7(3):1554\u20131585.", "ArticleIdList": ["PMC4586784", "26270676"]}, {"Citation": "Zhao Y., Tong C., Jiang J. Hedgehog regulates smoothened activity by inducing a conformational switch. Nature. 2007;450(7167):252\u2013258.", "ArticleIdList": ["17960137"]}, {"Citation": "Goetz S.C., Anderson K.V. The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 2010;11(5):331\u2013344.", "ArticleIdList": ["PMC3121168", "20395968"]}, {"Citation": "Robbins D.J., Fei D.L., Riobo N.A. The Hedgehog signal transduction network. Sci. Signal. 2012;5(246):re6.", "ArticleIdList": ["PMC3705708", "23074268"]}, {"Citation": "Briscoe J., Therond P.P. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 2013;14(7):416\u2013429.", "ArticleIdList": ["23719536"]}, {"Citation": "Po A., Ferretti E., Miele E., De Smaele E., Paganelli A., Canettieri G., Coni S., Di Marcotullio L., Biffoni M., Massimi L., Di Rocco C., Screpanti I., Gulino A. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J. 2010;29(15):2646\u20132658.", "ArticleIdList": ["PMC2928686", "20581804"]}, {"Citation": "Yao J., An Y., Wie J.S., Ji Z.L., Lu Z.P., Wu J.L., Jiang K.R., Chen P., Xu Z.K., Miao Y. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. Swiss Med. Wkly. 2011;141:w13208.", "ArticleIdList": ["21630164"]}, {"Citation": "Santini R., Pietrobono S., Pandolfi S., Montagnani V., D'Amico M., Penachioni J.Y., Vinci M.C., Borgognoni L., Stecca B. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene. 2014;33(38):4697\u20134708.", "ArticleIdList": ["PMC4180644", "24681955"]}, {"Citation": "Yoon C. Park do, J.; Schmidt, B.; Thomas, N.J.; Lee, H.J.; Kim, T.S.; Janjigian, Y.Y.; Cohen, D.J.; Yoon, S.S. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Clin. Cancer Res. 2014;20(15):3974\u20133988.", "ArticleIdList": ["PMC4135312", "24947926"]}, {"Citation": "Queiroz K.C., Ruela-de-Sousa R.R., Fuhler G.M., Aberson H.L., Ferreira C.V., Peppelenbosch M.P., Spek C.A. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene. 2010;29(48):6314\u20136322.", "ArticleIdList": ["20802532"]}, {"Citation": "Takahashi T., Kawakami K., Mishima S., Akimoto M., Takenaga K., Suzumiya J., Honma Y. Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells. Leuk. Res. 2011;35(5):638\u2013645.", "ArticleIdList": ["20971508"]}, {"Citation": "Lin T.L., Wang Q.H., Brown P., Peacock C., Merchant A.A., Brennan S., Jones E., McGovern K., Watkins D.N., Sakamoto K.M., Matsui W. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One. 2010;5(12):e15262.", "ArticleIdList": ["PMC3011010", "21203400"]}, {"Citation": "Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66(12):6063\u20136071.", "ArticleIdList": ["PMC4386278", "16778178"]}, {"Citation": "Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., Piccirillo S., Vescovi A.L., DiMeco F., Olivi A., Eberhart C.G. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007;25(10):2524\u20132533.", "ArticleIdList": ["PMC2610257", "17628016"]}, {"Citation": "Corcoran R.B., Scott M.P. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc. Natl. Acad. Sci. USA. 2006;103(22):8408\u20138413.", "ArticleIdList": ["PMC1462959", "16707575"]}, {"Citation": "Tang S.N., Fu J., Nall D., Rodova M., Shankar S., Srivastava R.K. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int. J. Cancer. 2012;131(1):30\u201340.", "ArticleIdList": ["PMC3480310", "21796625"]}, {"Citation": "Ramasamy T.S., Ayob A.Z., Myint H.H., Thiagarajah S., Amini F. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015;15:96.", "ArticleIdList": ["PMC4599442", "26457069"]}, {"Citation": "Buhrmann C., Kraehe P., Lueders C., Shayan P., Goel A., Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One. 2014;9(9):e107514.", "ArticleIdList": ["PMC4169561", "25238234"]}, {"Citation": "Zhang L., Li L., Jiao M., Wu D., Wu K., Li X., Zhu G., Yang L., Wang X., Hsieh J.T., He D. Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway. Cancer Lett. 2012;323(1):48\u201357.", "ArticleIdList": ["22484470"]}, {"Citation": "Wang X., Zhang N., Huo Q., Sun M., Dong L., Zhang Y., Xu G., Yang Q. Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway. Tumour Biol. 2014;35(11):10805\u201310813.", "ArticleIdList": ["25077927"]}, {"Citation": "Han J.B., Sang F., Chang J.J., Hua Y.Q., Shi W.D., Tang L.H., Liu L.M. Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli. Onco Targets Ther. 2013;6:1129\u20131138.", "ArticleIdList": ["PMC3753152", "23990729"]}, {"Citation": "Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002;3(3):221\u2013227.", "ArticleIdList": ["11875461"]}, {"Citation": "Orlowski R.Z., Baldwin A.S., Jr NF-kappaB as a therapeutic target in cancer. Trends Mol. Med. 2002;8(8):385\u2013389.", "ArticleIdList": ["12127724"]}, {"Citation": "Yang H., Dou Q.P. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr. Drug Targets. 2010;11(6):733\u2013744.", "ArticleIdList": ["PMC3306610", "20298150"]}, {"Citation": "Baltimore D. NF-kappaB is 25. Nat. Immunol. 2011;12(8):683\u2013685.", "ArticleIdList": ["21772275"]}, {"Citation": "Dai X., Zhang J., Arfuso F., Chinnathambi A., Zayed M.E., Alharbi S.A., Kumar A.P., Ahn K.S., Sethi G. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Exp. Biol. Med. (Maywood) 2015;240(6):760\u2013773.", "ArticleIdList": ["PMC4935211", "25854879"]}, {"Citation": "Gupta S.C., Sundaram C., Reuter S., Aggarwal B.B. Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta. 2010;1799(10-12):775\u2013787.", "ArticleIdList": ["PMC2955987", "20493977"]}, {"Citation": "Kaltschmidt B., Kaltschmidt C., Hofmann T.G., Hehner S.P., Droge W., Schmitz M.L. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 2000;267(12):3828\u20133835.", "ArticleIdList": ["10849002"]}, {"Citation": "Ehrhardt H., Fulda S., Schmid I., Hiscott J., Debatin K.M., Jeremias I. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene. 2003;22(25):3842\u20133852.", "ArticleIdList": ["12813457"]}, {"Citation": "Jennewein C., Karl S., Baumann B., Micheau O., Debatin K.M., Fulda S. Identification of a novel pro-apoptotic role of NF-kappaB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells. Oncogene. 2012;31(11):1468\u20131474.", "ArticleIdList": ["21822306"]}, {"Citation": "Guzman M.L., Rossi R.M., Karnischky L., Li X., Peterson D.R., Howard D.S., Jordan C.T. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105(11):4163\u20134169.", "ArticleIdList": ["PMC1895029", "15687234"]}, {"Citation": "Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., Kamat A.A., Spannuth W.A., Gershenson D.M., Lutgendorf S.K., Aggarwal B.B., Sood A.K. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin. Cancer Res. 2007;13(11):3423\u20133430.", "ArticleIdList": ["17545551"]}, {"Citation": "Chung S.S., Vadgama J.V. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling. Anticancer Res. 2015;35(1):39\u201346.", "ArticleIdList": ["PMC4290892", "25550533"]}, {"Citation": "Li Y., Ellis K.L., Ali S., El-Rayes B.F., Nedeljkovic-Kurepa A., Kucuk O., Philip P.A., Sarkar F.H. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas. 2004;28(4):e90\u2013e95.", "ArticleIdList": ["15097869"]}, {"Citation": "Moselhy J., Srinivasan S., Ankem M.K., Damodaran C. Natural Products That Target Cancer Stem Cells. Anticancer Res. 2015;35(11):5773\u20135788.", "ArticleIdList": ["PMC7523548", "26503998"]}, {"Citation": "Marucci C., Fumagalli G., Calogero F., Silvani A., Christodoulou M.S., Martinet N., Passarella D. Natural Products and Cancer Stem Cells. Curr. Pharm. Des. 2015;21(38):5547\u20135557.", "ArticleIdList": ["26429713"]}, {"Citation": "Vira D., Basak S.K., Veena M.S., Wang M.B., Batra R.K., Srivatsan E.S. Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer Metastasis Rev. 2012;31(3-4):733\u2013751.", "ArticleIdList": ["22752409"]}, {"Citation": "Kim Y.S., Farrar W., Colburn N.H., Milner J.A. Cancer stem cells: potential target for bioactive food components. J. Nutr. Biochem. 2012;23(7):691\u2013698.", "ArticleIdList": ["PMC4518442", "22704055"]}, {"Citation": "Burnett J., Newman B., Sun D. Targeting cancer stem cells with natural products. Curr. Drug Targets. 2012;13(8):1054\u20131064.", "ArticleIdList": ["22594473"]}, {"Citation": "Weber D.A., Wheat J.M., Currie G.M. Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: a review. Zhong Xi Yi Jie He Xue Bao. 2012;10(5):493\u2013503.", "ArticleIdList": ["22587968"]}, {"Citation": "Efferth T. Stem cells, cancer stem-like cells, and natural products. Planta Med. 2012;78(10):935\u2013942.", "ArticleIdList": ["22573366"]}, {"Citation": "McCubrey J.A., Steelman L.S., Abrams S.L., Misaghian N., Chappell W.H., Basecke J., Nicoletti F., Libra M., Ligresti G., Stivala F., Maksimovic-Ivanic D., Mijatovic S., Montalto G., Cervello M., Laidler P., Bonati A., Evangelisti C., Cocco L., Martelli A.M. Targeting the cancer initiating cell: the ultimate target for cancer therapy. Curr. Pharm. Des. 2012;18(13):1784\u20131795.", "ArticleIdList": ["22394167"]}]}], "History": [{"Year": "2015", "Month": "11", "Day": "14"}, {"Year": "2015", "Month": "12", "Day": "24"}, {"Year": "2015", "Month": "12", "Day": "28"}, {"Year": "2017", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28367074", "PMC5345336", "10.2174/1389202917666160803162309", "CG-18-156"]}}]}